ctrl K

Watchlist Price Alert

Lyell Immunopharma Inc. (LYEL)

NASDAQ: LYEL · Real-Time Price · USD

0.41

0.01 (1.33%)

At close: May 14, 2025, 3:59 PM

0.39

-3.82%

After-hours: May 14, 2025, 04:20 PM EDT

Lyell Immunopharma Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	61K	130K	84.68M	10.65M	7.76M	657K
Cost of Revenue	n/a	n/a	16.47M	14.54M	7.47M	n/a
Gross Profit	61K	130K	68.22M	-3.88M	281K	657K
Operating Income	-358.75M	-247.01M	-183.12M	-214.78M	-211.94M	-102.09M
Interest Income	24.07M	23.45M	7.05M	1.17M	5.94M	8.12M
Pretax Income	-342.99M	-234.63M	-183.12M	-250.22M	-204.47M	-129.38M
Net Income	-342.99M	-234.63M	-4.75M	-285.5M	-198.53M	-121.26M
Selling & General & Admin	52.04M	66.98M	117.31M	89.06M	46.88M	39.15M
Research & Development	171.6M	182.94M	159.19M	138.69M	182.24M	63.59M
Other Expenses	135.17M	-2.79M	1.89M	-2.32M	-9.43M	-35.41M
Operating Expenses	358.82M	247.14M	276.5M	225.43M	219.69M	102.75M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	358.82M	247.14M	276.5M	225.43M	219.69M	102.75M
Income Tax Expense	n/a	n/a	-178.36M	35.28M	-5.94M	-8.12M
Shares Outstanding (Basic)	261.48M	250.98M	247.08M	242.74M	246.58M	246.58M
Shares Outstanding (Diluted)	261.48M	250.98M	247.08M	242.74M	246.58M	246.58M
EPS (Basic)	-1.31	-0.93	-0.02	-1.18	-0.81	-0.49
EPS (Diluted)	-1.31	-0.93	-0.02	-1.18	-0.81	-0.49
EBITDA	-200.64M	-226.76M	-166.65M	-199.94M	-207.64M	-100.83M
EBIT	n/a	-247.01M	-187.06M	-214.78M	-211.94M	-102.09M
Depreciation & Amortization	n/a	20.25M	16.47M	14.54M	7.47M	4.38M